HARM REDUCTION FOR ALCOHOL PROBLEMS: EXPANDING TREATMENT OPTIONS. Part 2
- Authors: Zobin M.L1
-
Affiliations:
- Moscow drug addiction treatment centre
- Issue: Vol XLVI, No 1 (2014)
- Pages: 65-73
- Section: Articles
- Submitted: 20.06.2019
- Published: 15.03.2014
- URL: https://journals.eco-vector.com/1027-4898/article/view/13841
- DOI: https://doi.org/10.17816/nb13841
- ID: 13841
Cite item
Full Text
Abstract
Harm reduction strategy does not see complete abstinence as the only goal of treatment. Unreadiness for immediate rejection of alcohol consumption should not be a barrier to helping to reduce the negative effects of alcohol abuse, especially in cases where the standard treatments do not produce the expected results. Such an approach is consistent with the behavioral patterns of dependence and provides more treatment options, which would otherwise not be used.
Keywords
Full Text
СНИЖЕНИЯ ВРЕДА ПРИ АЛКОГОЛЬНЫХ ПРОБЛЕМАХ: РАСШИРЕНИЕ ВОЗМОЖНОСТЕЙ ЛЕЧЕНИЯ. Часть 2×
About the authors
Mikhail L Zobin
Moscow drug addiction treatment centre
Email: dr.zobin@yandex.ru
127055, Moscow, Sushchevskaya str., 21
References
- Говорин Н.В., Сахаров А.В. Алкогольное бремя соматического стационара. Томск: Изд-во «Иван Федоров», 2010. 160 с
- Завьялов В.Ю. Необъявленная психотерапия. М.: Академический Проект, Екатерингбург: Деловая книга, 1999. 250 с
- Егоров А.Ю., Крупицкий Е.М., Софронов А.Г. и др. Злоупотребление алкоголем у пациентов ургентного соматического стационара / Актуальные проблемы возрастной наркологии. Мат-лы Всероссийской междисциплинарной научно-практической конф. (Челябинск 15-16 ноября 2012 г.) [Под ред. Е.Н. Кривулина, Н.А. Бохана]. Челябинск: Изд-во ПИРС, 2012. С. 119‒120
- Крупицкий Е.М. Краткосрочное психотерапевтическое вмешательство в наркологии с позиции доказательной медицины // Неврологический вестник. 2010. №3. С. 25‒27
- Менделевич В.Д. Парадоксальность принципов современной российской наркологии // Российский психиатрический журнал. 2004. №6. С. 24‒29
- Организация стрессопсихотерапии больных алкоголизмом в амбулаторных условиях. Методические рекомендации Минздрава СССР. М., 1984. 12 с
- Сиволап Ю.П. Применение антидепрессантов в наркологической практике // Обозрение психиатрии и медицинской психологии. 2010. № 2. С. 49‒51
- Сиволап Ю.П. О применении психотропных средств в наркологии // Наркология. 2012. № 2. С. 81‒83
- Чернобровкина Т.В. О кодировании в аддиктологии в вопросах и ответах // Наркология. 2008. № 1. С. 62‒82
- Энтин Г.М. Еще раз к вопросу стресспсихотерапии алкоголизма по методу А.Р. Довженко // Журнал невропатол. и психиатр. 1991. Т. 91, № 2. С. 132‒133
- Adamson S.J., Heather N., Morton V. et al. Initial preference for drinking goal in the treatment of alcohol problems: II. Treatment outcomes // Alcohol Alcohol. 2010 Mar-Apr. Vol. 45(2). pp. 136‒142
- Addolorato G., Caputo F., Capristo E. et al. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study // Alcohol Alcohol 2002. Vol. 37. pp. 504‒508
- Addolorato G., Leggio L., Agabio R. et al. Baclofen: a new drug for the treatment of alcohol dependence // Int. J. Clin. Pract. 2006, Aug. Vol. 60(8). pp. 1003‒1008
- Addolorato G., Leggio L., Ferrulli A. et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study // Lancet. 2007. Vol. 370. pp. 1915‒1922
- Anton R.F., O’Malley S.S., Ciraulo D.A. et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial // JAMA 2006. Vol. 295. pp. 2003‒2017
- Anton R.F., Oroszi G., O’Malley S. et al. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study // Arch. Gen. Psychiatry. 2008. Vol. 65. pp. 135‒144
- Anton R.F., Pettinati H., Zweben A. et al. A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence // J. Clin. Psychopharmacol. 2004. Vol. 24. pp. 421‒428
- Babor T.F., Del Boca F.K. (Eds.). Treatment matching in alcoholism. Cambridge, UK: Cambridge University Press, 2003
- Baser O., Chalk M., Rawson R., Gastfriend D.R. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence // Am. J. Manag Care. 2011 Jun. Vol. 17, Suppl 8. Pp. 222‒234
- Bouza C., Angeles M., Munoz A., Amate J.M. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: A systematic review // Addiction. 2004. Vol. 99. pp. 811‒828
- Chamorro A.J., Marcos M., Mirón-Canelo J.A. et al. Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis // Addict Biol. 2012 May. Vol. 17(3). pp. 505‒512
- Chick J., Aschauer H., Hornik K., Investigators’ Group. Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology // Drug Alcohol Depend 2004. Vol. 74(1). pp. 61‒70
- Cloninger C.R., Sigvardsson S., Bohman M. Type I and type II alcoholism: An update // Alcohol Health and Research World. 1996. Vol. 20. pp. 18‒23
- Cohen E., Feinn R., Arias A., Kranzler H.R. Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions // Drug Alcohol Depend. 2007 Jan 12. Vol. 86(2-3). pp. 214‒221
- Colombo G., Agabio R., Carai M.A. et al. Ability of baclofen in reducing alcohol intake and withdrawal severity: I-Preclinical evidence // Alcohol Clin. Exp. Res. 2000. Vol. 24(1). pp. 58‒66
- Colombo G., Serra S., Brunetti G. et al. Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats // Drug Alcohol Depend. 2003. Vol. 70(1). pp. 105‒108
- De Sousa A., De Sousa A. A one-year pragmatic trial of naltrexone vs. disulfiram in the treatment of alcohol dependence // Alcohol and Alcoholism. 2004. Vol. 39, № 6, pp. 528‒531
- De Sousa A., De Sousa A. An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence // Alcohol and Alcoholism. 2005. Vol. 40, № 6. pp. 545‒548
- De Sousa A.A., De Sousa J., Kapoor H. An open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence // J. Subst Abuse Treat. 2008 Jun. Vol. 34(4). pp. 460‒463
- Diehl A., Ulmer L., Mutschler J. et al. Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients // Alcohol Alcohol. 2010 May-Jun. Vol. 45(3). pp. 271‒277
- Ducci F., Goldman D. Genetic approaches to addiction: genes and alcohol // Addiction. 2008. Vol. 103. pp. 1414‒1428
- Dundon W., Lynch K.G., Pettinati H.M., Lipkin C. Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy // Alcohol Clin. Exp. Res. 2004. Vol. 28(7). pp. 1065‒1073
- Ernst D.B., Pettinati H.M., Weiss R.D. et al. An intervention for treating alcohol dependence: relating elements of Medical Management to patient outcomes with implications for primary care // Ann Fam Med. 2008. Vol. 6. pp. 435‒440
- Farren C.K., Scimeca M., Wu R., Malley S.O. A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence // Drug Alcohol Depend. 2009 Jan 1. Vol. 99(1-3). pp. 317‒321
- Fiellin D.A., Reid M.C., O’Connor P.G. New therapies for alcohol problems: application to primary care // Am. J. Med. 2000. Vol. 108(3). pp. 227‒237
- Finney J.W., Hahn A.C., Moos R.H. The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects // Addiction. 1996. Vol. 91(12). pp. 1773‒1796
- Flannery B.A., Garbutt J.C., Cody M.W. et al. Baclofen for alcohol dependence: A preliminary open-label study // Alcoholism: Clinical and Experimental Research. 2004. Vol. 28. pp. 1517‒1523
- Fleming M.F., Mundt M.P., French M.T. et al. Brief physician advice for problem drinkers: Long-term efficacy and benefit-cost analysis // Alcoholism: Clinical and Experimental Research. 2002. Vol. 26. pp. 36‒43
- Freyer-Adam J., Coder B., Baumeister S.E. et al. Brief alcohol intervention for general hospital inpatients: a randomized controlled trial // Drug Alcohol Depend. 2008 Mar 1. Vol. 93(3). pp. 233‒243
- Garbutt J.C., Kampov-Polevoy A.B., Gallop R. et al. Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial // Alcohol Clin. Exp. Res. 2010 Nov. Vol. 34(11). pp. 1849‒1857
- Garbutt J.C., Kranzler H.R., O’Malley S.S. et al. Efficacy and tolerability of long- acting injectable Naltrexone for alcohol dependence: A randomized controlled trial // Journal of the American Medical Association. 2005. Vol. 293. pp. 1617‒1625
- Garcia F., Moral R., de Torres P. et al. Effectiveness of medical counseling for alcoholic patients and patients with excessive alcohol consumption seen in primary care. [Article in Spanish] // Atencion Primaria. 2003. Vol. 31. pp. 146‒154
- Harris B.R., Prendergast M.A., Gibson D.A. et al. Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors // Alcohol Clin. Exp. Res. 2002. Vol. 26 (12). pp. 1779‒1793
- Heather N., Adamson S.J., Raistrick D. et al. Initial preference for drinking goal in the treatment of alcohol problems: I. Baseline differences between abstinence and non-abstinence groups // Alcohol Alcohol. 2010 Mar-Apr. Vol. 45(2). pp. 128‒135
- Hodgins D. Can patients with alcohol use disorders return to social drinking? Yes, so what should we do about it? // Canadian Journal of Psychiatry. 2005. Vol. 50. pp. 264‒265
- Hodgins D., Leigh G., Milne R., Gerrish R. Drinking goal selection in behavioral self-management treatment of chronic alcoholics // Addictive Behaviors. 1997. Vol. 22. pp. 247‒255
- Hungerford D.W., Pollock D.A. Emergency department services for patients with alcohol problems: Research directions // Academic Emergency Medicine. 2003. Vol. 10. pp. 79‒84
- Institute of Medicine. Improving the Quality of Health Care for Mental and Substance-Use Conditions: Quality Chasm Series, National Academy Press, 2006
- Johnson B.A. Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study // Alcohol Clin. Exp. Res. 2004. Vol. 28. pp. 1137–1144
- Johnson B.A. Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment // CNS Drugs. 2004. Vol. 18(15). pp. 1105‒1118
- Johnson B.A., Ait-Daoud N. Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients // Curr Pharm Des. 2010. Vol. 16(19). pp. 2103‒2112
- Johnson B.A, Ait-Daoud N., Seneviratne C. et al. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking // Am. J. Psychiatry. 2011. Vol. 168(3). pp. 265‒275
- Johnson B.A., Roache J.D., Javors M.A. et al. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial // J.A.M.A. 2000. Vol. 284(8). pp. 963‒971
- Johnson B.A., Rosenthal N., Capece J.A. et al. Topiramate for treating alcohol dependence: a randomized controlled trial // J.A.M.A. 2007. Vol. 298. pp. 1641‒1651
- Jonas D.E., Garbutt J.C., Amick H.R. et al. Behavioral Counseling After Screening for Alcohol Misuse in Primary Care: A Systematic Review and Meta-analysis for the U.S. Preventive Services Task Force // Ann. Intern Med. 2012 Sep 25. doi: 10.7326/0003-4819-157-9-201211060-00544
- Kaner E.F., Dickinson H.O., Beyer F., Pienaar E., Schlesinger C., Campbell F. et al. The effectiveness of brief alcohol interventions in primary care settings: a systematic review // Drug Alcohol Rev. 2009. Vol. 28. pp. 301–23
- Kenna G.A. Medications acting on the serotonergic system for the treatment of alcohol dependent patients // Curr Pharm Des. 2010. Vol. 16(19). pp. 2126‒2135
- Kenna G.A., Lomastro T.L., Schiesl A., Leggio L., Swift R.M. Review of topiramate: an antiepileptic for the treatment of alcohol dependence // Curr Drug Abuse Rev. 2009 May. Vol. 2(2). pp. 135‒142
- Kranzler H.R., Burleson J.A., Brown J., Babor T.F. Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics // Alcohol Clin. Exp. Res. 1996. Vol. 20(9). pp. 1534‒1541
- Kranzler H.R., Pierucci-Lagha A., Feinn R., Hernandez-Avila C. Effects of ondansetron in early-versus late-onset alcoholics: a prospective, open-label study // Alcohol Clin. Exp. Res. 2003. Vol. 27(7). pp. 1150‒1155
- Laaksonen E., Koski-Jannes A., Salaspuro M. et al. A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence // Alcohol Alcohol. 2008. Vol. 43. pp. 53‒61
- Lesch O.M., Walter H. Subtypes of alcoholism and their role in therapy // Alcohol Alcohol Suppl. 1996 Mar. Vol. 1. pp. 63‒67. Review
- Lovinger D.M. Serotonin’s role in alcohol’s effects on the brain // Alcohol Health Res World. 1997. Vol. 21(2). pp. 114‒120. Review
- Ma J.Z., Ait-Daoud N., Johnson B.A. Topiramate reduces the harm of excessive drinking: implications for public health and primary care // Addiction. 2006. Vol. 101(11). pp. 1561‒1568
- Mann K., Lehert P., Morgan M.Y. The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis // Alcohol Clin Exp Res. 2004. Vol. 28. pp. 51‒63
- Martensen-Larsen O. Five years’ experience with disulfiram in the treatment of alcoholics // Quarterly Journal of Studies on Alcohol. 1953. Vol. 14, № 3. pp. 406‒418
- Mason B.J., Goodman A.M., Chabac S., Lehert P. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation // J. Psychiatr Res. 2006. Vol. 40. pp. 383‒393
- Mason B.J., Salvato F.R., Williams L.D. et al. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence // Arch Gen Psychiatry. 1999 Aug. Vol. 56(8). pp. 719‒724
- McQueen J., Howe T.E., Allan L., Mains D., Hardy V. Brief interventions for heavy alcohol users admitted to general hospital wards. Cochrane Database of Systematic Reviews 2011, Issue 8. Art. No.: CD005191. doi: 10.1002/14651858.CD005191.pub3
- Morley K.C., Teesson M., Reid S.C. et al. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial // Addiction. 2006. Vol. 101. pp. 1451‒1462
- Moss H.B., Chen C.M., Yi H.Y. Subtypes of alcohol dependence in a nationally representative sample // Drug Alcohol Depend. 2007 Dec 1. Vol. 91(2-3). pp. 149‒158
- Moss H.B., Chen C.M., Yi H.Y. Prospective follow-up of empirically derived Alcohol Dependence subtypes in wave 2 of the National Epidemiologic Survey on Alcohol And Related Conditions (NESARC): recovery status, alcohol use disorders and diagnostic criteria, alcohol consumption behavior, health status, and treatment seeking // Alcohol Clin Exp Res. 2010 Jun. Vol. 34(6). pp. 1073‒1083
- Muckle W., Muckle J., Welch V., Tugwell P. Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuse. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD006747. doi: 10.1002/14651858.CD006747.pub2
- Muzyk A.J., Rivelli S.K., Gagliardi J.P. Defining the role of baclofen for the treatment of alcohol dependence: a systematic review of the evidence // CNS Drugs. 2012 Jan 1. Vol. 26(1). pp. 69‒78
- Nunes E.V., Levin F.R. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis // JAMA 2004. Vol. 291(15). pp. 1887‒1896
- Olmsted C.L., Kockler D.R. Topiramate for alcohol dependence // Ann. Pharmacother. 2008 Oct. Vol. 42(10). pp. 1475‒1480
- Oslin D.W., Berrettini W., Kranzler H.R. et al. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients // Neuropsychopharmacology. 2003. Vol. 28. pp. 1546‒1542
- Pascoe J.E., Williams K.L., Mukhopadhyay P. et al. Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeys // Psychoneuroendocrinology. 2008 May. Vol. 33(4). pp. 478-486
- Pettinati H.M., O’Brien C.P., Rabinowitz A.R. et al. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking // J. Clin. Psychopharmacol. 2006 Dec. Vol. 26(6). pp. 610‒625
- Pettinati H.M., Silverman B.L., Battisti J.J. et al. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence // Alcohol Clin. Exp. Res. 2011 Oct. Vol. 35(10). pp. 1804‒1811
- Pettinati H.M., Volpicelli J.R., Kranzler H.R. et al. Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype // Alcohol Clin Exp Res. 2000. Vol. 24(7). pp. 1041‒1049
- Pettinati H.M., Weiss R.D., Miller W.R. et al. Medical Management Treatment Manual: A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of the Treatment for Alcohol Dependence. COMBINE Monograph Series, Volume 2 (DHHS Publication No. 04-5289), National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 2004
- Richardson K., Baillie A., Reid S. et al. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? // Addiction. 2008 Jun. Vol. 103(6). pp. 953‒959
- Rösner S., Hackl-Herrwerth A., Leucht S. et al. Acamprosate for alcohol dependence. Cochrane Database of Systematic Reviews 2010, Issue 9. Art. No.: CD004332. doi: 10.1002/14651858.CD004332.pub2
- Rösner S., Hackl-Herrwerth A., Leucht S. et al. Opioid antagonists for alcohol dependence. Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No.: CD001867. doi: 10.1002/14651858.CD001867. pub3
- Rösner S., Leucht S., Lehert P., Soyka M. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes // J. Psychopharmacol. 2008 Jan. Vol. 22(1). pp. 11‒23
- Saitz R. Alcohol screening and brief intervention in primary care: Absence of evidence for efficacy in people with dependence or very heavy drinking // Drug Alcohol Rev. 2010 Nov. Vol. 29(6). pp. 631‒640
- Sass H., Soyka M., Mann K., Zieglgansberger W. Relapse prevention by acamprosate: Results from a placebo-controlled study on alcohol dependence // Archives of General Psychiatry. 1996. Vol. 53. pp. 673‒680
- Schmidt L., Room R. Cross-cultural applicability in international classifications and research on alcohol dependence // Journal of Studies on Alcohol. 1999. Vol. 60. pp. 448‒462
- Sellers E.M., Toneatto T., Romach M.K. et al. Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence // Alcohol Clin. Exp. Res. 1994. Vol. 18(4). pp. 879‒885
- Skradski S., White H.S. Topiramate blocks kainate-evoked cobalt influx into cultured neurons // Epilepsia. 2000. Vol. 41, Suppl 1. рp. 45‒47
- Srisurapanont M., Jarusuraisin N. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 2005; CD001867
- Streeton C., Whelan G. Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: A meta-analysis of randomized controlled trials // Alcohol and Alcoholism. 2001. Vol. 36. pp. 544‒552
- Suh J.J., Pettinati H.M., Kampman K.M., O’Brien C.P. The status of disulfiram: a half of a century later //Journal of Clinical Psychopharmacology. 2006. Vol. 26, № 3. pp. 290‒302
- Swift R., Pettinati H.M. Choosing pharmacotherapies for the COMBINE study‒process and procedures: An investigational approach to combination pharmacotherapy for the treatment of alcohol dependence // Journal of Studies on Alcohol. 2005. Vol. 66(Suppl. 15). pp. 141‒147
- Torrens M., Fonseca F., Mateu G., Farré M. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis // Drug Alcohol Depend 2005. Vol. 78(1). pp. 1‒22
- US Preventive Services Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement // Ann Intern Med. 2004. Vol. 140. pp. 554‒556
- Walters G.D. The heritability of alcohol abuse and dependence: A meta-analysis of behavior genetic research // Am J. Drug Alcohol Abuse. 2002. Vol. 28. pp. 557‒584
- Weiss R.D., O’Malley S.S., Hosking J.D. et al. Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study // J. Stud Alcohol Drugs. 2008. Vol. 69(6). pp. 878‒884
- White H.S., Brown S.D., Woodhead J.H. et al. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism // Epilepsia. 2000. Vol. 41, Suppl 1. pp. 17‒20
- Williams K.L., Broadbear J.H., Woods J.H. Noncontingent and response-contingent intravenous ethanol attenuates the effect of naltrexone on hypothalamic-pituitary-adrenal activity in rhesus monkeys // Alcohol Clin. Exp. Res. 2004. Vol. 28. pp. 566‒171
Supplementary files
![](/img/style/loading.gif)